Phase III clinical trial - Sein

Ouvert depuis le: 01.24.2022
Site: Paris
Public cible
A Double blind randomized phase III study of pravastatin vs placebo as primary prevention of severe;subcutaneous breast fibrosis in hyper-radiosensitive identified patients with breast cancer
Description de l'essai

To compare the impact of Pravastatin on the occurrence of grade = 2 breast;fibrosis in a selected breast cancer patient population considered at high risk of;severe breast fibrosis occurrence (identified by the NovaGray RILA Breast« test) vs;placebo.